Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @euapmbrussels
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @euapmbrussels
-
#EAPM Croatia Presidency Conference “Defining the healthcare ecosystem to determine value”#PersonalisedMedicine#Innovation#healthcare
When: March 24, 2020
Where: University Foundation, Brussels
Registration Open!http://tiny.cc/v25jjz Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
The fight against
#Cancer is ongoing:#WorldCancerDay
and the EU’s broader health-care issues
"#Patients need action, citizens need it and, put bluntly in this ‘cash is king’ world, the economy needs it." http://shorturl.at/erOX0Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
The new
#EAPM#newsletter has been published - "An extra day in February - plenty to do!"
Check it out:
https://www.euapm.eu/pdf/EAPM_Bulletin_Issue_59_February_2020.pdf …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
EAPM proslijedio/la je Tweet
An
#AI Strategy for#Healthcare in Europe. Why and how? Check the new article http://bit.ly/3auvGH4 and the blog http://intel.ly/30E5TrN .@IntelHealth@euapmbrusselsHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Check out new
#EAPM article on#genomics and the new fast-developing#technology - Patchwork’ rules won’t mend those#genes -https://cutt.ly/Lrcw6eNHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#EAPMCongress Thanks to Benjamin Gannon, VP Intl Access, Policy & Advocacy from@myriadgenetics to give us his view on#Biomarkers,#MolecularDiagnostics and the new company challengesHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
EAPM proslijedio/la je Tweet
MedTech Europe's Tanja Valentin speaking during the HTA session at the #EAPMConferencepic.twitter.com/TjSQSdAGLY
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
EAPM proslijedio/la je Tweet
#MedTechWeek Perspectives:@euapmbrussels looks at the state of play and the future of#personalisedmedicine. Read the full blog here: http://bit.ly/2On5VzJ pic.twitter.com/fJeC3IhPmL
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Flora Giorgio from DG SANTE
@EU_Health now on stage presenting the key points of the#HTA EU proposal#European Commission – and insights: Finnish and Croatia Presidency willing to make progress on the file#EU2019FI#eu2020hrHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Tiemo Wölken
@woelken - the voice of the European Parliament#EUparliament presents in#HTA and#Access session – underlining the relevance of#HTA at the European LevelHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
EAPM proslijedio/la je Tweet
There is no innovation if it does not provide value for a patient. Value frameworks should help to make innovation accessible. The reality is different! All stakeholders must collaborate to enable patients to access valuable innovations.
#EAPMConference @MSDInventpic.twitter.com/YvtkipZ5ma
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#EAPMCongress Now it is the turn of Paul Naish, Director, Oncology Advocacy and Government Affairs from@AstraZeneca, who is bringing a perspective on#Biomarkers,#MolecularDiagnostics and the public#Health dimensionHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#EAPM – Need to speed ‘awesome’#developments in#personalised medicine,#EAPMCongress toldhttps://cutt.ly/we3JCNWHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Excellent contribution of Gabriele Grom
@GabrieleGrom, Associate Vice President for Central Eastern Europe@MSDInvents - in the Evidence Framework Session#EAPMCongress#PersonalisedMedicine - Only few countries provide timely access to new#oncology medicineHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#EAPMCongress The next session is just starting – Evidence Framework - Christine Chomienne gives the French Perspective of Evidence Framework from clinical reimbursement of#PersonalisedMedicineHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#EAPMCongress Maciej Gajewski, Head Intl Government Affairs & Policy from@AlexionPharma now on stage presents industry perspective on#Orphandrugs and#rarediseases - There is a well-functioning innovation ecosystem to address ambitious goals for rare diseasesHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#EAPMCongress next up is Simone Boselli from@eurordis giving the patient perspective on the need to ensure access to recent scientific developments#Orphandrugs#rarediseasesHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#EAPMCongress Plenary session 1 ready to roll - Generating alignment in the area of Orphan Regulation Alastair Kent, Formerly Director of Genetic Alliance UK@GeneticAll_UK#Orphandrugs#rarediseasesHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Ortwin Schulte
@GermanyintheEU#eucouncil addresses a keynote speech at#EAPMCongress. The pharmaceutical industry will face several challenges with#Brexit#HealthcareHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
EAPM proslijedio/la je Tweet
The 2nd day of
@euapmbrussels EAPM Annual Congress starting now. Today’s topics -#Orphan regulation,#HTA & access,#biomarkers and of course - a glimpse to what is on the new political term 2019-2024.pic.twitter.com/7Q9ltbdJep
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.